查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840832

农业生物技术市场（按技术、产品类型、作物类型、应用和最终用户划分）—2025-2032 年全球预测

Agricultural Biotechnology Market by Technology, Product Type, Crop Type, Application, End-user - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，农业生物技术市场规模将成长至 2,571.8 亿美元，复合年增长率为 7.07%。

主要市场统计数据
基准年2024年 1488.1亿美元
预计2025年 1586.9亿美元
预测年份：2032年 2571.8亿美元
复合年增长率（%） 7.07%

简洁而全面的定位，探讨塑造农业生物技术未来的科学、监管和商业性力量的融合

农业生物技术领域正处于曲折点，科学创新、不断发展的法规和不断变化的贸易动态正在汇聚在一起，重新定义农业实践和商业策略：成熟的基因编辑平台、扩大微生物解决方案的应用、将高通量基因组学整合到育种管道中，以及诊断和数位工具在作物和牲畜管理中发挥越来越大的作用。

跨地区、跨商品类别的相关人员面临着一个通用的迫切需求：将实验室的进展转化为可落地的解决方案，从而显着提高作物的復原力、生产力和永续性。同时，研究中心、种子製造商和监管机构等机构参与者正在努力适应新的资料管治、智慧财产权和社会认可框架。因此，从发现到应用的道路正变得更加迭代和协作，其中生物技术公司、种苗公司和农民协会之间的伙伴关係发挥关键作用。

本介绍为高阶主管层探索变革性转变、政策影响、市场区隔的细微差别、区域动态、企业策略和可行建议奠定了基础，强调需要采取一种综合方法，平衡技术抱负与务实部署、相关人员参与以及与不断发展的监管规范的一致性。

最近的科学突破、共同研究模式和数位诊断如何加速农业生物技术的创新并重塑其商业化路径

农业生物技术领域正在经历一场变革性的转变，其驱动力在于创新，这些创新正在改变技术可行性的速度和范围。基于 CRISPR 的基因编辑和其他精准工程工具正在缩短产生目标性状改良所需的时间，从而实现能够应对新型生物和生物威胁的育种週期。同时，基因组学和 DNA定序的进步使数据生成更加民主化，为育种者和研究人员提供了关于性状结构的可行见解，并使标记辅助选择能够补充新的编辑方法。

微生物生物技术和合成生物学正在扩展土壤健康、养分管理和生物害虫防治的套件，促进减少对化学投入依赖的综合解决方案。分子诊断和数位表型分析使得疾病和胁迫的早期检测成为可能，从而提高了决策和管理效率。这些技术变革伴随着制度变革：私人公司和公共研究机构之间的共同研究模式正在激增，开放资料计画正在加速知识的传播。

整体而言，这些转变正在重塑产品开发路径，缩短某些类型创新的开发时间，同时提升监管策略、公众参与和价值链整合的重要性。因此，那些将研发重点与可扩展的交付模式相结合并建立相关人员信任的组织，将更有能力将科学进步转化为商业性和社会可行的成果。

基于证据的检验，探讨 2025 年美国关税如何重塑农业生物技术供应链、国际研究合作和商业化策略。

美国2025年关税的实施和贸易政策的调整，对农业生物技术价值链产生了复杂的波动，影响了投入、跨国合作以及下游商业化策略。对某些进口产品征收关税增加了专用实验室试剂、昂贵育种材料和某些生物製品的直接成本，迫使製造商和研究机构重新评估筹资策略和库存管理。为此，采购团队已实现供应商基础多元化，并加快了替代供应商的资格审查，以缓解眼前的衝击。

贸易壁垒也影响了国际研究合作，导致研究机构之间生物材料和序列测定服务的转移更加复杂，海关审查更加严格，前置作业时间也更长。因此，一些合作研究计划调整了物流，更依赖国内产能和云端基础的资料交换，而非实体样本运输。此外，关税提升了区域製造和关键投入品本地生产的战略重要性，刺激了旨在建立有韧性的供应链和减轻贸易波动影响的投资决策。

从商业化角度来看，关税带来的成本压力使得企业更重视优化营运效率和市场进入途径。企业优先考虑能够最大限度地降低跨境复杂性的产品形式和包装，同时强调监管协调和双边协议，以促进贸易顺畅。简而言之，关税环境促使企业重新评估整个农业生物技术生态系统的供应链弹性、合作模式和市场进入策略。

详细的细分概述揭示了技术分类、作物分类、应用优先顺序和最终用户概况如何决定研究重点和商业化路径

要了解市场动态，需要详细了解技术类别、产品类型、作物重点、应用领域和最终用户生态系统。技术领域涵盖生物资讯学、基因工程、基因组学和分子标记、微生物生物技术、分子诊断、合成生物学和组织培养；基因工程进一步细分为 CRISPR/Cas9、基因编辑和转基因方法，基因组学和分子标记又细分为 DNA定序和标记辅助选择。产品类型涵盖动物生物技术产品、生物肥料、生物农药、基因改造作物、基因改造种子和植物生长调节剂，每种产品都需要不同的监管、生产和分销模式。

在谷类领域，观察大麦、玉米、稻米和小麦，可以发现育种重点和性状组合的差异。在油籽和豆类领域，观察油菜籽、大豆、向日葵、鹰嘴豆、扁豆和豌豆等子类别，可以发现一系列农艺和市场驱动因素。应用重点在于作物改良、病害管理、环境永续性、牲畜健康和生产力以及土壤肥力管理，作物改良本身则扩展到生物胁迫耐受性、抗虫害和产量。最终用户范围广泛，从农业合作社和生物技术公司到农民和种植者、政府和监管机构、研究机构和种子製造商，每个用户都对采用週期、购买行为和产品设计产生不同的影响。

综上所述，这些细分揭示了技术选择如何与作物和应用重点相互交织，从而塑造研发开发平臺和商业化路径。例如，针对玉米非生物胁迫耐受性而客製化的基因编辑方法，与针对蔬菜系统病虫害综合治理而设计的微生物生物农药，其监管途径和最终用户采用动态将有所不同。认识到这些微妙的相互依存关係，对于协调产品开发、相关人员参与和市场推广策略至关重要。

美洲、欧洲、中东和非洲以及亚太地区的法规结构、基础设施能力和招募实践如何塑造差异化的商业化策略

区域动态对整个农业生物技术领域的技术采用模式、法规结构和商业策略有重大影响。在美洲，创新中心和成熟的种子及生物技术公司支撑着一个强大的生态系统，强调扩充性的商业化、一体化的供应链以及积极的公私伙伴关係研究。该地区通常引领新性状田间试验的部署，重点关注商品作物作物的性状改良可以在农场层级带来即时的效益。

欧洲、中东和非洲地区环境复杂多元，监管方式、市场接受度和生态学重点差异庞大。监管严格程度和公众参与度将决定采用路径，尤其是在基因工程和新型生物方法方面，而气候适应和永续性目标将推动人们对以环境韧性为导向的解决方案产生兴趣。同时，不同国家的市场成熟度各不相同，因此需要製定量身定制的参与策略并与相关人员进行对话。

在亚太地区，高人口密度和多样化的种植系统使得对提高生产力、抗逆性和病害管理解决方案的需求日益迫切。一些市场正在迅速采用数位工具和诊断平台，以补充蓬勃发展的种子产业和日益增长的国内生物技术能力。在所有地区，当地法规结构、基础设施能力和供应链稳健性的相互作用将决定部署的可行性和速度，因此，因地制宜成为企业策略和公共规划的核心要素。

领先的农业生物技术公司正在利用策略性企业倡议和能力建设趋势，将其科学平台转变为可扩展、有弹性的商业业务

主要企业正在应对一个复杂的环境，其特点是技术创新迅速、监管审查严格以及客户期望不断变化。市场参与企业正在透过多种策略手段脱颖而出，包括对基因编辑和微生物解决方案进行有针对性的研发投资、与种苗公司和研究机构建立策略联盟，以及进行垂直整合以确保获得关键投入和分销管道。许多公司也优先考虑监管科学能力和公共关係，以加快核准并建立相关人员的信任。

企业策略日益强调支援多条产品线的平台能力，例如模组化基因编辑套件、标准化微生物生产流程以及将基因转导与农场管理实践相结合的整合诊断技术。伙伴关係和授权协议在利用互补专业知识、加快测试速度和扩大商业化方面继续发挥关键作用。此外，供应链弹性已成为董事会层面关注的重点，推动了对区域製造、裁员计画和供应商多元化的投资。

在人才方面，企业越来越多地聘请由分子生物学家、监管科学家、数据分析师和田间农学家组成的多学科团队，以连接研发和商业化。智慧财产权策略正在平衡某些领域的开放式创新模式，以促进生态系统发展，同时保护核心资产。总而言之，这些公司的倡议凸显了企业向综合经营模式的转变，该模式将科学研究能力与商业性执行和相关人员的参与相结合。

为产业领导者提供明确、优先的营运和策略步骤，以加速采用、降低贸易和供应风险并协调监管和产品开发工作

产业领导者应优先考虑一系列切实可行的倡议，以利用技术进步，同时管理监管、市场和供应链风险。首先，在研发生命週期的早期阶段纳入监管策略，以协调研究设计、资料产生和公众沟通。其次，投资区域製造和供应链多元化，以最大限度地减少跨境关税波动的影响，并确保及时获得关键试剂和生物投入。

第三，我们将在整个价值链上建立伙伴关係，包括与种子製造商、农业合作社、研究机构和服务供应商建立合作伙伴关係，共同开发能够解决最终用户约束和应用障碍的交付机制。第四，我们将透过将数位诊断和数据分析整合到我们的产品中，打造能够改善检测、决策支援和效能监控的附加价值服务，从而加强客户维繫。第五，我们将专注于将人才培养成跨职能团队，以应对科学、监管和商业化挑战，同时维持适应性学习文化。

最后，我们积极与监管机构、政策制定者和民间社会相关人员合作，在安全数据、环境评估和社会经济效益方面建立透明度。这种合作可以减少不确定性，提高公众接受度，并为切实可行的监管协调铺平道路，从而支持大规模的负责任创新。

透明、多学科的研究途径结合专家访谈、文献综合和强有力的检验，确保获得可操作和检验的见解

本分析所采用的调查方法结合了定性和定量分析，以确保研究的稳健性、透明度和可重复性。主要研究包括对高级研发领导、监管专家、采购负责人和农民代表进行结构化访谈，以了解他们在开发平臺、供应链和应用动态方面的具体经验。此外，我们还与政策专家和技术顾​​问进行了磋商，以补充这些访谈，从而为不断发展的法律规范及其对贸易政策的影响提供背景资讯。

二次分析利用同行评审文献、政府出版刊物、技术白皮书和公开的企业资料，对研究结果进行三角检验并检验技术声明。资料品质保证包括交叉引用多个独立资讯来源、检查技术分类的一致性以及请专家审查初步结论。透过透明地记录关于技术就绪程度、监管时间表和供应链配置的假设，我们认识到并解决了其中的局限性。

总体而言，该调查方法强调多学科证据综合、相关人员检验和迭代改进，以便在检验资讯的基础上为决策者提供可行的见解。

整合技术前景、供应链弹性和相关人员的参与，揭示实现农业生物技术持久影响的实用途径

总而言之，农业生物技术领域正在发展成为一个多层面的生态系统，其成功取决于科学进步、监管条件、供应链韧性以及相关人员的参与。基因编辑、基因组学、微生物解决方案和数位诊断技术的融合，使得有针对性的干预措施能够显着提高不同种植系统和畜牧业的韧性和生产力。然而，将科学潜力转化为永续的市场成果，需要研发、监管、生产和市场应用等方面的策略协调。

不断变化的贸易政策和关税措施凸显了供应链策略和本地能力的重要性。同时，按技术、产品类型、目标作物、应用和最终用户特征进行细分，揭示了不同的影响路径，需要量身定制的经营模式和伙伴关係策略。投资于监管科学、本地製造和综合服务交付，同时保持透明的相关人员参与的公司，将最有可能实现商业性和社会效益。

最终，务实的创新才是前进的方向——将技术承诺转化为可行的部署策略、负责任的管治以及对最终用户价值的明确关注。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 加速在耐旱玉米品种中采用 CRISPR Cas9 基因编辑
  • 扩大微生物生物肥料的市场渗透率，改善田间作物的土壤健康
  • 利用卫星整合表型平台加速谷物性状发现
  • 增加对植物基因组分析的投资，以开发适应气候的作物品种
  • 将人工智慧疾病预测模型与生物技术洞察相结合，以研究病原体抗性
  • 监管协调努力影响全球基因改造油籽作物贸易
  • 开发基于奈米生物技术的种子披衣以提高豆科植物的养分吸收效率
  • 精准基因驱动与害虫综合管理在入侵物种控制的协同效应
  • 基于CRISPR的耐旱性状在主要作物中的快速扩展
  • 整合人工智慧驱动的表型分析与遥感探测，实现精准作物管理

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 农业生物技术市场（按技术）

  • 生物资讯学
  • 基因工程
    • CRISPR/Cas9和基因编辑
    • 基因工程
  • 基因组学和分子标记
    • DNA序列分析
    • 标记辅助选择（MAS）
  • 微生物生物技术
  • 分子诊断
  • 合成生物学
  • 组织培养

9. 农业生物技术市场（依产品类型）

  • 动物生物技术产品
  • 生物肥料
  • 生物农药
  • 基因改造作物/基因改造种子
  • 植物生长调节剂

10. 农业生物技术市场（依作物类型）

  • 序列
    • 大麦
    • 玉米
    • 米
    • 小麦
  • 水果和蔬菜
  • 油籽
    • 油菜籽
    • 大豆
    • 向日葵
  • 脉衝
    • 鹰嘴豆
    • 扁豆
    • 豌豆

第11章农业生物技术市场（按应用）

  • 作物改良
    • 非生物胁迫耐受性
    • 抗虫害
    • 产量提高
  • 疾病管理
  • 环境永续性
  • 牲畜健康和生产力
  • 土壤肥力管理

12. 农业生物技术市场（依最终用户）

  • 农业合作社
  • 生技公司
  • 农民和生产者
  • 政府和监管机构
  • 研究机构
  • 种子製造商

13. 农业生物技术市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章农业生物技术市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国农业生物技术市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • ADAMA Ltd
    • Agrinos AS
    • Andermatt Biocontrol AG
    • Arcadia Biosciences, Inc.
    • BASF SE
    • Bayer CropScience AG
    • Bioworks, Inc.
    • Certis USA LLC
    • CIBO Technologies, Inc.
    • Corteva, Inc.
    • Evogene Ltd.
    • FMC Corporation
    • Indigo Ag, Inc.
    • Koppert Biological Systems NV
    • KWS SAAT SE & Co. KGaA
    • Limagrain
    • Marrone Bio Innovations, Inc.
    • Nufarm Limited
    • Performance Plants Inc.
    • Pivot Bio, Inc.
    • Symbiomics SA
    • Syngenta AG
    • UPL Limited
    • Valent BioSciences LLC
Product Code: MRR-221461476867

The Agricultural Biotechnology Market is projected to grow by USD 257.18 billion at a CAGR of 7.07% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 148.81 billion
Estimated Year [2025] USD 158.69 billion
Forecast Year [2032] USD 257.18 billion
CAGR (%) 7.07%

A concise yet comprehensive orientation to the converging scientific, regulatory, and commercial forces shaping the future of agricultural biotechnology

The agricultural biotechnology sector stands at an inflection point where scientific innovation, regulatory evolution, and shifting trade dynamics intersect to redefine agronomic practice and commercial strategy. This introduction synthesizes the drivers that matter most to executives and technical leaders: the maturation of gene editing platforms, expanded applications of microbial solutions, the integration of high-throughput genomics into breeding pipelines, and the increasing role of diagnostic and digital tools in crop and livestock management.

Across geographies and commodity classes, stakeholders face a common imperative to translate laboratory advances into field-ready solutions that deliver measurable improvements in resilience, productivity, and sustainability. Concurrently, institutional actors such as research centers, seed manufacturers, and regulatory agencies are navigating new frameworks for data governance, intellectual property, and public acceptance. As a result, the pathway from discovery to adoption is becoming more iterative and collaborative, with partnerships between biotech firms, seed houses, and farmer cooperatives playing a pivotal role.

This introduction sets the stage for an executive-level exploration of transformative shifts, policy impacts, market segmentation nuance, regional dynamics, corporate strategies, and actionable recommendations. It highlights the need for integrated approaches that balance technological ambition with pragmatic deployment, stakeholder engagement, and alignment to evolving regulatory norms.

How recent scientific breakthroughs, collaborative research models, and digital diagnostics are jointly accelerating innovation and reshaping commercialization pathways in agricultural biotechnology

The landscape of agricultural biotechnology is undergoing transformative shifts driven by innovations that are altering both the pace and scope of what is technically feasible. CRISPR-based gene editing and other precision engineering tools have reduced the time required to generate targeted trait improvements, enabling breeding cycles that are more responsive to emerging biotic and abiotic threats. At the same time, advances in genomics and DNA sequencing have democratized data generation, providing breeders and researchers with actionable insights into trait architecture and enabling marker-assisted selection to complement newer editing methods.

Microbial biotechnology and synthetic biology are expanding the toolkit for soil health, nutrient management, and biological pest control, fostering integrated solutions that reduce reliance on chemical inputs. Molecular diagnostics and digital phenotyping are enabling earlier detection of disease and stress, which in turn improves decision-making and management effectiveness. These technological shifts are accompanied by institutional changes: collaborative research models between private companies and public research institutions are proliferating, and open-data initiatives are accelerating knowledge diffusion.

Collectively, these shifts are reshaping product development pathways, shortening time-to-field for certain classes of innovations while increasing the importance of regulatory strategy, public engagement, and value-chain integration. As a result, organizations that align R&D priorities with scalable delivery models and stakeholder trust-building will be better positioned to translate scientific advances into commercially and socially viable outcomes.

An evidence-based examination of how the 2025 United States tariff measures reshaped supply chains, international research collaboration, and commercialization strategies across agricultural biotechnology

The imposition of tariffs and trade policy adjustments by the United States in 2025 created a complex ripple across agricultural biotechnology value chains, affecting inputs, cross-border collaborations, and downstream commercialization strategies. Tariffs on certain categories of imports raised the direct cost of specialized lab reagents, high-value breeding material, and certain bioproducts, which compelled manufacturers and research organizations to reassess sourcing strategies and inventory management. In response, procurement teams diversified supplier bases and accelerated qualification of alternate vendors to mitigate near-term disruptions.

Trade barriers also influenced international research collaborations, as increased customs scrutiny and longer lead times complicated the transfer of biological materials and sequencing services between institutions. Consequently, some collaborative projects restructured logistics to rely more on in-country capacity or cloud-based data exchange rather than physical sample transfers. Moreover, tariffs elevated the strategic importance of regional manufacturing and local production of critical inputs, prompting investment decisions aimed at building resilient supply chains and reducing exposure to trade volatility.

From a commercialization perspective, tariff-driven cost pressures sharpened the focus on operational efficiency and route-to-market optimization. Companies prioritized product formats and packaging that minimized cross-border complexities while emphasizing regulatory harmonization and bilateral agreements to facilitate smoother trade. In sum, the tariff environment catalyzed a reassessment of supply chain resilience, collaboration modalities, and market access strategies across the agricultural biotechnology ecosystem.

In-depth segmentation overview revealing how technology classes, crop categories, application priorities, and end-user profiles jointly determine research focus and commercialization pathways

Understanding market dynamics requires a granular appreciation of technology classes, product types, crop focus, application domains, and the end-user ecosystem. The technology landscape spans bioinformatics, genetic engineering, genomics and molecular markers, microbial biotechnology, molecular diagnostics, synthetic biology, and tissue culture, with genetic engineering further differentiated into CRISPR/Cas9 and gene editing versus transgenic approaches, while genomics and molecular markers extend into DNA sequencing and marker-assisted selection. Product types encompass a range from animal biotechnology products and biofertilizers to biopesticides, genetically modified crops and transgenic seeds, as well as plant growth regulators, each demanding distinct regulatory, production, and distribution models.

Crop segmentation highlights the importance of cereals, fruits and vegetables, oilseeds, and pulses; within cereals, specific attention to barley, maize, rice, and wheat reveals divergent breeding priorities and trait portfolios, and within oilseeds and pulses the subcategories of rapeseed, soybean, sunflower, chickpea, lentil, and pea illuminate varied agronomic and market drivers. Applications cluster around crop improvement, disease management, environmental sustainability, livestock health and productivity, and soil fertility management, with crop improvement itself branching into abiotic stress tolerance, pest resistance, and yield enhancement. End users range from agricultural cooperatives and biotech companies to farmers and growers, government and regulatory agencies, research institutions, and seed manufacturers, each exerting different influence on adoption cycles, purchasing behavior, and product design.

Taken together, these segmentation lenses reveal how technology choices intersect with crop and application priorities to shape R&D pipelines and commercialization paths. For example, a gene editing approach tailored for abiotic stress tolerance in maize will engage different regulatory pathways and end-user adoption dynamics than a microbial biopesticide designed for integrated pest management in vegetable systems. Recognizing these nuanced interdependencies is essential for aligning product development, stakeholder engagement, and go-to-market strategies.

How regional regulatory frameworks, infrastructure capacity, and adoption readiness across the Americas, Europe Middle East & Africa, and Asia-Pacific shape differentiated commercialization strategies

Regional dynamics materially influence technology adoption patterns, regulatory frameworks, and commercial strategies across the agricultural biotechnology landscape. In the Americas, innovation hubs and well-established seed and biotech firms anchor a robust ecosystem that emphasizes scalable commercialization, integrated supply chains, and active private-public research partnerships. This region often leads in field trial deployment for novel traits and maintains a strong emphasis on commodity-oriented crops where trait improvements deliver immediate farm-level benefits.

The Europe, Middle East & Africa region presents a heterogeneous environment where regulatory approaches, market acceptance, and agroecological priorities vary widely. Regulatory stringency and public engagement shape adoption pathways, particularly for genetic engineering and novel biologicals, while climate adaptation and sustainability goals drive interest in solutions oriented toward environmental resilience. Meanwhile, differing market maturity levels across countries necessitate tailored entry strategies and local stakeholder dialogues.

In the Asia-Pacific region, high population density and diverse cropping systems create urgent demand for productivity enhancements, stress tolerance, and disease management solutions. Rapid adoption of digital tools and diagnostic platforms in some markets complements an active seed industry and growing domestic biotech capability. Across all regions, the interplay between local regulatory frameworks, infrastructure capacity, and supply chain robustness determines the feasibility and pace of deployment, making regional adaptation a central element of corporate strategy and public policy planning.

Strategic corporate moves and capability-building trends that leading agricultural biotechnology firms use to translate scientific platforms into scalable and resilient commercial operations

Leading companies in agricultural biotechnology are navigating a complex environment marked by rapid technological change, regulatory scrutiny, and evolving customer expectations. Market participants are differentiating through several strategic levers including targeted R&D investment in gene editing and microbial solutions, strategic alliances with seed companies and research institutions, and vertical integration to secure access to critical inputs and distribution channels. Many firms are also prioritizing regulatory science capacity and public affairs to facilitate approvals and build stakeholder trust.

Corporate strategies increasingly emphasize platform capabilities that enable multiple product lines, such as modular gene editing toolkits, standardized microbial production processes, and integrated diagnostics that link trait deployment with on-farm management practices. Partnerships and licensing deals continue to play a prominent role in accessing complementary expertise, accelerating time-to-trial, and scaling commercialization. Additionally, supply chain resilience has become a board-level concern, prompting investments in regional manufacturing, redundancy planning, and vendor diversification.

From a talent perspective, firms are recruiting multidisciplinary teams that combine molecular biologists, regulatory scientists, data analysts, and field agronomists to bridge R&D and commercialization. Intellectual property strategies are being balanced with open innovation models in select domains to foster ecosystem development while protecting core assets. Collectively, these corporate moves underscore a shift toward integrated business models that couple scientific capability with commercial execution and stakeholder engagement.

Clear, prioritized operational and strategic steps for industry leaders to accelerate adoption, mitigate trade and supply risks, and align regulatory engagement with product development

Industry leaders should prioritize a set of actionable initiatives to capitalize on technological advances while managing regulatory, market, and supply chain risks. First, embed regulatory strategy early in the R&D lifecycle to align trial design, data generation, and public communication; this reduces friction at later stages and accelerates path-to-market for complex trait solutions. Second, invest in regional manufacturing and supply chain diversification to minimize exposure to cross-border tariff volatility and to ensure timely access to critical reagents and biological inputs.

Third, cultivate partnerships across the value chain, including seed manufacturers, agricultural cooperatives, research institutions, and service providers, to co-develop delivery mechanisms that address end-user constraints and adoption barriers. Fourth, integrate digital diagnostics and data analytics with product offerings to create value-added services that improve detection, decision support, and performance monitoring, thereby strengthening customer relationships and retention. Fifth, focus talent development on cross-functional teams that can navigate scientific, regulatory, and commercialization challenges while maintaining adaptive learning cultures.

Finally, proactively engage with regulators, policymakers, and civil society stakeholders to build transparency around safety data, environmental assessments, and socioeconomic benefits. Such engagement can reduce uncertainty, improve public acceptance, and create pathways for pragmatic regulatory harmonization that supports responsible innovation at scale.

A transparent, interdisciplinary research approach combining expert interviews, literature synthesis, and robust validation to ensure actionable and verifiable insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches designed to ensure robustness, transparency, and reproducibility. Primary research included structured interviews with senior R&D leaders, regulatory specialists, procurement officers, and farmer representatives to capture lived experience across development pipelines, supply chains, and adoption dynamics. These interviews were supplemented by consultations with policy experts and technical advisers who provided context on evolving regulatory frameworks and trade policy impacts.

Secondary analysis drew upon peer-reviewed literature, government and intergovernmental publications, technical white papers, and publicly available company disclosures to triangulate findings and validate technical assertions. Data quality assurance included cross-referencing multiple independent sources, applying consistency checks to technology classification, and subjecting preliminary conclusions to expert review panels. Limitations were acknowledged and addressed by transparently documenting assumptions related to technology readiness, regulatory timelines, and supply chain configurations.

Overall, the methodological approach emphasized interdisciplinary evidence synthesis, stakeholder validation, and iterative refinement to produce insights that are practical for decision-makers while grounded in verifiable information.

Synthesis of technological promise, supply chain resilience, and stakeholder engagement that defines a pragmatic path for realizing durable impact in agricultural biotechnology

In conclusion, the agricultural biotechnology landscape is maturing into a multifaceted ecosystem where scientific advances, regulatory alignment, supply chain resilience, and stakeholder engagement determine who succeeds. The convergence of gene editing, genomics, microbial solutions, and digital diagnostics is enabling targeted interventions that can materially improve resilience and productivity across diverse cropping systems and livestock sectors. However, translating scientific potential into durable market outcomes requires strategic orchestration across R&D, regulatory affairs, manufacturing, and market adoption efforts.

Trade policy shifts and tariff measures have underscored the importance of supply chain strategy and regional capability. At the same time, segmentation by technology, product type, crop focus, application, and end-user profile reveals differentiated pathways to impact that necessitate tailored business models and partnership strategies. Firms that invest in regulatory science, regional manufacturing, and integrated service offerings while maintaining transparent stakeholder engagement will be best positioned to realize commercial and societal benefits.

Ultimately, the pathway forward is one of pragmatic innovation: aligning technological promise with feasible deployment strategies, responsible governance, and a clear focus on end-user value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Accelerating adoption of CRISPR Cas9 gene editing for drought tolerant maize varieties
  • 5.2. Expanding market penetration of microbial biofertilizers to enhance soil health in row crops
  • 5.3. Utilization of satellite integrated phenotyping platforms to accelerate trait discovery in cereals
  • 5.4. Rising investments in plant genome sequencing to unlock climate resilient crop breeds
  • 5.5. Emergence of AI driven predictive disease models combined with biotech pathogen resistance insights
  • 5.6. Regulatory harmonization efforts shaping global trade in genetically modified oilseed crops
  • 5.7. Development of nanobiotechnology based seed coatings to improve nutrient uptake efficiency in legumes
  • 5.8. Synergy between precision gene drives and integrated pest management in controlling invasive species
  • 5.9. Rapid expansion of CRISPR-based drought tolerance traits in staple crops
  • 5.10. Integration of AI-driven phenotyping and remote sensing for precision crop management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agricultural Biotechnology Market, by Technology

  • 8.1. Bioinformatics
  • 8.2. Genetic Engineering
    • 8.2.1. CRISPR/Cas9 & Gene Editing
    • 8.2.2. Transgenic Technology
  • 8.3. Genomics and Molecular Markers
    • 8.3.1. DNA Sequencing
    • 8.3.2. Marker-Assisted Selection (MAS)
  • 8.4. Microbial Biotechnology
  • 8.5. Molecular Diagnostics
  • 8.6. Synthetic Biology
  • 8.7. Tissue Culture

9. Agricultural Biotechnology Market, by Product Type

  • 9.1. Animal Biotechnology Products
  • 9.2. Biofertilizers
  • 9.3. Biopesticides
  • 9.4. Genetically Modified (GM) Crops / Transgenic Seeds
  • 9.5. Plant Growth Regulators

10. Agricultural Biotechnology Market, by Crop Type

  • 10.1. Cereals
    • 10.1.1. Barley
    • 10.1.2. Maize
    • 10.1.3. Rice
    • 10.1.4. Wheat
  • 10.2. Fruits & Vegetables
  • 10.3. Oilseeds
    • 10.3.1. Rapeseed
    • 10.3.2. Soybean
    • 10.3.3. Sunflower
  • 10.4. Pulses
    • 10.4.1. Chickpea
    • 10.4.2. Lentil
    • 10.4.3. Pea

11. Agricultural Biotechnology Market, by Application

  • 11.1. Crop Improvement
    • 11.1.1. Abiotic Stress Tolerance
    • 11.1.2. Pest Resistance
    • 11.1.3. Yield Enhancement
  • 11.2. Disease Management
  • 11.3. Environmental Sustainability
  • 11.4. Livestock Health & Productivity
  • 11.5. Soil Fertility Management

12. Agricultural Biotechnology Market, by End-user

  • 12.1. Agricultural Cooperatives
  • 12.2. Biotech Companies
  • 12.3. Farmers & Growers
  • 12.4. Government & Regulatory Agencies
  • 12.5. Research Institutions
  • 12.6. Seed Manufacturers

13. Agricultural Biotechnology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Agricultural Biotechnology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Agricultural Biotechnology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. ADAMA Ltd
    • 16.3.2. Agrinos AS
    • 16.3.3. Andermatt Biocontrol AG
    • 16.3.4. Arcadia Biosciences, Inc.
    • 16.3.5. BASF SE
    • 16.3.6. Bayer CropScience AG
    • 16.3.7. Bioworks, Inc.
    • 16.3.8. Certis USA LLC
    • 16.3.9. CIBO Technologies, Inc.
    • 16.3.10. Corteva, Inc.
    • 16.3.11. Evogene Ltd.
    • 16.3.12. FMC Corporation
    • 16.3.13. Indigo Ag, Inc.
    • 16.3.14. Koppert Biological Systems NV
    • 16.3.15. KWS SAAT SE & Co. KGaA
    • 16.3.16. Limagrain
    • 16.3.17. Marrone Bio Innovations, Inc.
    • 16.3.18. Nufarm Limited
    • 16.3.19. Performance Plants Inc.
    • 16.3.20. Pivot Bio, Inc.
    • 16.3.21. Symbiomics S.A.
    • 16.3.22. Syngenta AG
    • 16.3.23. UPL Limited
    • 16.3.24. Valent BioSciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. AGRICULTURAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. AGRICULTURAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AGRICULTURAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE,